These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17942517)

  • 1. Influence of oligoclonal IgM specificity in multiple sclerosis disease course.
    Villar L; García-Barragán N; Espiño M; Roldán E; Sádaba M; Gómez-Rial J; González-Porqué P; Alvarez-Cermeño J
    Mult Scler; 2008 Mar; 14(2):183-7. PubMed ID: 17942517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands.
    Bosca I; Villar LM; Coret F; Magraner MJ; Simó-Castelló M; Alvarez-Cermeño JC; Casanova B
    Mult Scler; 2010 Jul; 16(7):810-5. PubMed ID: 20538705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.
    Villar LM; Espiño M; Cavanillas ML; Roldán E; Urcelay E; de la Concha EG; Sádaba MC; Arroyo R; González-Porqué P; Alvarez-Cermeño JC
    Clin Immunol; 2010 Oct; 137(1):51-9. PubMed ID: 20621566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
    Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
    Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.
    Villar LM; Sádaba MC; Roldán E; Masjuan J; González-Porqué P; Villarrubia N; Espiño M; García-Trujillo JA; Bootello A; Alvarez-Cermeño JC
    J Clin Invest; 2005 Jan; 115(1):187-94. PubMed ID: 15630459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment.
    García-Barragán N; Villar LM; Espiño M; Sádaba MC; González-Porqué P; Alvarez-Cermeño JC
    Eur J Neurol; 2009 Mar; 16(3):380-5. PubMed ID: 19175382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of the IgM oligoclonal bands against myelin lipids in multiple sclerosis.
    Ribes García S; Casanova Estruch B; Gómez Pajares F; Juan Blanco MA
    J Neuroimmunol; 2021 Oct; 359():577698. PubMed ID: 34450374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome.
    Monreal E; Sainz de la Maza S; Costa-Frossard L; Walo-Delgado P; Zamora J; Fernández-Velasco JI; Villarrubia N; Espiño M; Lourido D; Lapuente P; Toboso I; Álvarez-Cermeño JC; Masjuan J; Villar LM
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
    Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G
    J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.
    Villar LM; Masjuan J; González-Porqué P; Plaza J; Sádaba MC; Roldán E; Bootello A; Alvarez-Cermeño JC
    Ann Neurol; 2003 Feb; 53(2):222-6. PubMed ID: 12557289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes.
    Magraner MJ; Bosca I; Simó-Castelló M; García-Martí G; Alberich-Bayarri A; Coret F; Alvarez-Cermeño JC; Martí-Bonmatí L; Villar LM; Casanova B
    Neuroradiology; 2012 Jan; 54(1):5-12. PubMed ID: 21327771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
    Villar LM; Espiño M; Roldán E; Marín N; Costa-Frossard L; Muriel A; Alvarez-Cermeño JC
    Mult Scler; 2011 Jun; 17(6):690-4. PubMed ID: 21436320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.
    Álvarez-Cermeño JC; Muñoz-Negrete FJ; Costa-Frossard L; Sainz de la Maza S; Villar LM; Rebolleda G
    J Neurol Sci; 2016 Jan; 360():41-4. PubMed ID: 26723970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
    Frau J; Villar LM; Sardu C; Secci MA; Schirru L; Ferraro D; Coghe G; Lorefice L; Fenu G; Bedin R; Sola P; Marrosu MG; Cocco E
    J Neurol; 2018 Feb; 265(2):424-430. PubMed ID: 29273846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
    Siritho S; Freedman MS
    J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on anti-myelin antibodies in patients with multiple sclerosis.
    Nobile-Orazio E; Spagnol G; Daverio R; Riboni L; Macchi R; Francomano E; Scarlato G
    Riv Neurol; 1987; 57(1):13-9. PubMed ID: 3629125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.
    Quintana E; Ortega FJ; Robles-Cedeño R; Villar ML; Buxó M; Mercader JM; Alvarez-Cermeño JC; Pueyo N; Perkal H; Fernández-Real JM; Ramió-Torrentà L
    Mult Scler; 2017 Nov; 23(13):1716-1726. PubMed ID: 28067602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.